Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DDAVP | Ferring Pharmaceuticals | N-018938 RX | 1984-03-30 | 1 products, RLD, RS |
DDAVP | Ferring Pharmaceuticals | N-019955 RX | 1995-09-06 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
ddavp | New Drug Application | 2022-09-28 |
desmopressin acetate | ANDA | 2025-02-19 |
nocdurna | New Drug Application | 2023-10-19 |
Code | Description |
---|---|
J2597 | Injection, desmopressin acetate, per 1 mcg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Nocturnal enuresis | D053206 | — | N39.44 | — | — | 2 | 3 | 2 | 7 |
Enuresis | D004775 | — | R32 | — | — | 2 | 3 | 2 | 7 |
Urinary incontinence | D014549 | — | R32 | — | — | 2 | 3 | 1 | 6 |
Aortic valve stenosis | D001024 | EFO_0000266 | — | — | — | — | 1 | — | 1 |
Pathologic constriction | D003251 | — | — | — | — | — | 1 | — | 1 |
Von willebrand diseases | D014842 | EFO_0003910 | D68.0 | — | — | — | 1 | — | 1 |
Eye diseases | D005128 | EFO_0003966 | H44 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Drug common name | Desmopressin |
INN | desmopressin |
Description | Desmopressin is a synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function. It has a role as a vasopressin receptor agonist, a renal agent and a diagnostic agent. |
Classification | Protein |
Drug class | vasoconstrictors (vasopressin derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O |
PDB | — |
CAS-ID | 16679-58-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1429 |
ChEBI ID | 4450 |
PubChem CID | 5311065 |
DrugBank | DB00035 |
UNII ID | ENR1LLB0FP (ChemIDplus, GSRS) |